Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose–response manner: a randomized, double-blind, placebo-controlled study
Yutaka Osuga, Yoshifumi Seki, Masataka Tanimoto, Takeru Kusumoto, Kentarou Kudou, Naoki Terakawa
Topics & Concepts
LeuprorelinMedicinePlaceboEndometriosisVisual analogue scalePelvic painTriptorelinAdverse effectPlacebo-controlled studyRandomized controlled trialUrologyAnesthesiaInternal medicineLuteinizing hormoneGonadotropin-releasing hormoneSurgeryHormoneDouble blindPathologyAlternative medicineEndometriosis Research and TreatmentPregnancy-related medical researchMenopause: Health Impacts and Treatments